08:14 AM EST, 11/12/2024 (MT Newswires) -- Wave Life Sciences ( WVE ) reported a Q3 loss Tuesday of $0.47 per diluted share, swinging from earnings of $0.07 a year earlier.

Analysts polled by Capital IQ expected a loss of $0.29.

The company reported no revenue for the quarter ended Sept. 30 compared with $49.2 million a year earlier.

Analysts surveyed by Capital IQ expected $13.1 million.

Cash and cash equivalents were $310.9 million as of Sept. 30, which is expected to fund operations into 2027, the company said.